UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of
Earliest Event Reported):
|
May
13, 2010
|
CAVITATION
TECHNOLOGIES, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
333-138074
|
|
20-4907818
|
(State
or other jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
|
|
|
|
|
10019
Canoga Ave,
Chatsworth,
California
|
|
91311
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
|
|
818-718-0905
Former
name or former address, if changed since last report
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
This
current report contains forward-looking statements as that term is defined in
the
Private Securities
Litigation Reform Act
of 1995. These statements relate to future events
or our future results of operation or future financial performance, including,
but not limited to, the following: statements relating to our ability to raise
sufficient capital to finance our planned operations, our ability to develop
brand recognition with resellers and consumers, develop our current and future
products, increase sales and our estimates of cash expenditures for the next 12
months. In some cases, you can identify forward-looking statements by
terminology such as “may”, “should”, “intends”, “expects”, “plans”,
“anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue”
or the negative of these terms or other comparable terminology. These statements
are only predictions and involve known and unknown risks, uncertainties and
other factors, including the risks in the section entitled “Risk Factors”, which
may cause our or our industry’s actual results, levels of activity or
performance to be materially different from any future results, levels of
activity or performance expressed or implied by these forward-looking
statements.
Although
we believe that the expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity or
performance. You should not place undue reliance on these statements, which
speak only as of the date that they were made. These cautionary statements
should be considered with any written or oral forward-looking statements that we
may issue in the future. Except as required by applicable law, including the
securities laws of the United States, we do not intend to update any of the
forward-looking statements to conform these statements to reflect actual
results, later events or circumstances or to reflect the occurrence of
unanticipated events.
In this
report, unless otherwise specified, all dollar amounts are expressed in United
States dollars and all references to “common shares” refer to the common shares
in our capital stock.
As used
in this current report and unless otherwise indicated, the terms “we”, “us” and
“our company” refer to Cavitation Technologies, Inc and to our wholly owned
subsidiary, HydroDynamic Technology, Inc.
Item
1
.0
1 Entry into a Material Definitive
Agreement
On May
13, 2010, the Board of Directors of Cavitation Technologies, Inc. approved an
assignment to Cavitation Technologies, Inc., of a patent assignment agreement
between Roman Gordon and Hydrodynamic Technology, Inc. originally dated July 1,
2008. The terms of the agreement provide that Mr. Gordon is to be
paid a royalty equal to 5% of the gross sales amount resulting from the
licensing or leasing of products embodying the technology previously developed
by Mr. Gordon.
On May
13, 2010, the Board of Directors of Cavitation Technologies, Inc. approved an
assignment to Cavitation Technologies, Inc., of a patent assignment agreement
between Igor Gorodnistky and Hydrodynamic Technology, Inc. originally dated July
1, 2008. The terms of the agreement provide that Mr. Gorodnitsky is
to be paid a royalty equal to 5% of the gross sales amount resulting from the
licensing or leasing of products embodying the technology previously developed
by Mr. Gorodnitsky.
ITEM
9.01 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND
EXHIBITS.
10.1
Patent Assignment Agreement between
Roman Gordon and Hydrodynamic Technology, Inc. dated July 1,
2008.
10.2
Patent Assignment Agreement between Igor
Gorodnitsky and Hydrodynamic Technology, Inc. dated July 1,
2008.
10.3
Assignment of Roman Gordon Patent
Assignment Agreement to Cavitation Tecnhologies, Inc.
10.4
Assignment of Igor Gorodnitsky Patent
Assignment Agreement to Cavitation Tecnhologies, Inc.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated:
May 17, 2010
|
|
|
|
|
|
By:
|
/s/
Roman Gordon
|
|
|
Roman
Gordon
|
|
|
Chief
Executive Officer
|